Crossmark

ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT)

Published Online: 2021-11-09

Authors

Choi, Jae Duck

Kim, Tae Jin

Jeong, Byong Chang

Jeon, Hwang Gyun

Jeon, Seong Soo

Kang, Min Yong

Yeom, Seon Yong

Seo, Seong Il
License Information

Text and Data Mining valid from 2021-11-09

Version of Record valid from 2021-11-09
More Information

Article History

Received: 17 February 2021

Accepted: 16 September 2021

First Online: 9 November 2021

Competing interests

: The authors declare no competing interests.

Document is current